Alpha 2.0
Login Register
» Articles » PMID: 9302310

Follow-up of Patients with Thyroid Carcinoma

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1997 Sep 26
PMID 9302310
Citations 7
Authors
R D UTIGER
Affiliations
Soon will be listed here.
Citing Articles

A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma.

Nakayama M, Okizaki A, Sakaguchi M, Ishitoya S, Uno T, Sato J Medicine (Baltimore). 2015; 94(28):e1191.

PMID: 26181567 PMC: 4617082. DOI: 10.1097/MD.0000000000001191.

Differentiated thyroid cancer-personalized therapies to prevent overtreatment.

Luster M, Weber T, Verburg F Nat Rev Endocrinol. 2014; 10(9):563-74.

PMID: 24981455 DOI: 10.1038/nrendo.2014.100.

Radioiodine for remnant ablation and therapy of metastatic disease.

Reiners C, Hanscheid H, Luster M, Lassmann M, Verburg F Nat Rev Endocrinol. 2011; 7(10):589-95.

PMID: 21826102 DOI: 10.1038/nrendo.2011.134.

Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinoma.

Verburg F, Dietlein M, Lassmann M, Luster M, Reiners C Eur J Nucl Med Mol Imaging. 2008; 36(3):343-6.

PMID: 19050874 DOI: 10.1007/s00259-008-0997-5.

The emerging role of pituitary tumor transforming gene in tumorigenesis.

Tfelt-Hansen J, Kanuparthi D, Chattopadhyay N Clin Med Res. 2006; 4(2):130-7.

PMID: 16809406 PMC: 1483889. DOI: 10.3121/cmr.4.2.130.